Prnews


 Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model

Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model

March 25, 2025 01:32 AM AEDT| By Cision

HCLTech and Western Union to set up a new India-based technology center to foster innovation NOIDA, India, March 24, 2025 /PRNewswire/ -- HCLTech and Western Union announce a strate...

 Sermonix and Regor Announce Strategic Collaboration to Optimize Regor's Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics

Sermonix and Regor Announce Strategic Collaboration to Optimize Regor's Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics

March 25, 2025 01:30 AM AEDT| By Cision

Partnership aims to develop efficacious and well-tolerated treatments for advanced metastatic breast cancer COLUMBUS, Ohio, and CAMBRIDGE, Mass., March 24, 2025 /PRNewswire/ -- Sermonix Pharma...

 Abler Nordic, Livelihoods Funds, Musim Mas, and Temasek Foundation Launch Blended Finance Initiative on Sustainable Oil Palm to Combat Deforestation and Aim to Support at least 400 Smallholders

Abler Nordic, Livelihoods Funds, Musim Mas, and Temasek Foundation Launch Blended Finance Initiative on Sustainable Oil Palm to Combat Deforestation and Aim to Support at least 400 Smallholders

March 24, 2025 01:00 PM AEDT| By Cision

SINGAPORE, March 24, 2025 /PRNewswire/ -- Impact fund manager Abler Nordic has partnered with Temasek Foundation, a Singapore-based philanthropic organisation that drives impact programmes in Asi...

 GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia

GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia

March 24, 2025 01:00 PM AEDT| By Cision

Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ruxolitinib Nearly all myelofibrosis patients globally are estimated...

 CPIC Estable MMF Launches on HashKey Chain with $100M First-Day Subscriptions

CPIC Estable MMF Launches on HashKey Chain with $100M First-Day Subscriptions

March 24, 2025 01:00 PM AEDT| By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- HashKey Chain announced that the tokenized USD Money Market Fund, "CPIC Estable MMF", initiated and managed by CPIC Investment Management (H....

"Hanwha Life Plants Seeds of AI Innovation in Vietnam"

March 24, 2025 12:30 PM AEDT| By Cision

– Fostering AI Talents through Informatics Olympiad Sponsorship 6th Informatics Olympiad concluded with record-breaking participation, sponsored by Hanwha Life for the second consecutive yea...

 Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology

Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology

March 24, 2025 12:03 PM AEDT| By Cision

Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare TAOYUAN, March 24, 2025 /PRNewswire/ -- As the demand for surgical precision and faster patient recovery continue...

 HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar

HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar

March 24, 2025 12:00 PM AEDT| By Cision

KUALA LUMPUR, Malaysia, March 24, 2025 /PRNewswire/ -- As the Hari Raya Aidilfitri celebration approaches, Hong Leong Bank and Hong Leong Islamic Bank ("HLB" or the "Bank") ha...

 FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

March 24, 2025 12:00 PM AEDT| By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- FuSure Reinsurance ("FuSure") is pleased to announce that, following four years of steady growth, it has successfully secured a long-term insur...

 ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

March 24, 2025 12:00 PM AEDT| By Cision

SHANGHAI, March 24, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the successful completion of the Phase III clinical study of AK0901,...

 ARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Skies and the Low-Altitude Economy

ARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Skies and the Low-Altitude Economy

March 24, 2025 12:00 PM AEDT| By Cision

TAIPEI, March 24, 2025 /PRNewswire/ -- Continuous innovation in drone technology has become a key driving force behind the rapid development of the low-altitude economy. With the ongoing advancement o...

 Evolve: The Latest GPU Benchmark Suite

Evolve: The Latest GPU Benchmark Suite

March 24, 2025 11:30 AM AEDT| By Cision

Revolutionary tool redefines performance evaluation for the graphics industry BREDA, Netherlands, March 24, 2025 /PRNewswire/ -- Traverse Research, one of the leading companies in graphics rese...

 CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

March 24, 2025 11:15 AM AEDT| By Cision

SUZHOU, China, March 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced...

 Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections

Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections

March 24, 2025 11:15 AM AEDT| By Cision

SHANGHAI, March 24, 2025 /PRNewswire/ -- 2025 CWIEME Shanghai is proud to announce its 10th anniversary that will unfold at the Shanghai World Expo Exhibition & Convention Center on June 25-27. As...

 AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

March 24, 2025 11:00 AM AEDT| By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shing...

 Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

March 24, 2025 11:00 AM AEDT| By Cision

SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures...

 Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX

Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX

March 24, 2025 11:00 AM AEDT| By Cision

HONG KONG, March 24, 2025 /PRNewswire/ -- CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong, is proud to announ...

 Strider Named to Fast Company's 2025 List of Most Innovative Companies

Strider Named to Fast Company's 2025 List of Most Innovative Companies

March 24, 2025 11:00 AM AEDT| By Cision

Strategic intelligence firm ranked in the top ten for most innovative security company TOKYO, March 24, 2025 /PRNewswire/ -- Strider Technologies, Inc., the leading provider of strategic intellig...

 Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

March 24, 2025 10:56 AM AEDT| By Cision

-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Eval...

 Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

March 24, 2025 10:30 AM AEDT| By Cision

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical deve...

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Recent Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.